G D Long

1.2k total citations
22 papers, 930 citations indexed

About

G D Long is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, G D Long has authored 22 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 5 papers in Pathology and Forensic Medicine and 5 papers in Oncology. Recurrent topics in G D Long's work include Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). G D Long is often cited by papers focused on Hematopoietic Stem Cell Transplantation (12 papers), Acute Myeloid Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (5 papers). G D Long collaborates with scholars based in United States, Australia and United Kingdom. G D Long's co-authors include Lawrence R. DeChatelet, Pamela S. Shirley, DA Bass, Michaël Thomas, Myron S. Cohen, Nelson J. Chao, David A. Rizzieri, Sandra J. Horning, Karl G. Blume and Mitchell E. Horwitz and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Infection and Immunity.

In The Last Decade

G D Long

22 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G D Long United States	14	305	278	204	202	140	22	930
G. Del Toro United States	13	341 1.1×	344 1.2×	481 2.4×	163 0.8×	118 0.8×	25	1.6k
Süreyya Savaşan United States	16	286 0.9×	261 0.9×	208 1.0×	99 0.5×	84 0.6×	81	943
Jiří Vorlíček Czechia	17	492 1.6×	147 0.5×	227 1.1×	268 1.3×	77 0.6×	98	969
Liming Bao United States	23	188 0.6×	197 0.7×	503 2.5×	193 1.0×	155 1.1×	71	1.3k
Tamio Koizumi Japan	21	217 0.7×	380 1.4×	433 2.1×	181 0.9×	200 1.4×	75	1.3k
N Murayama Japan	15	160 0.5×	184 0.7×	248 1.2×	192 1.0×	175 1.3×	43	878
A Okano Japan	17	439 1.4×	372 1.3×	283 1.4×	307 1.5×	67 0.5×	40	1.3k
Mark Goodman United States	16	287 0.9×	137 0.5×	260 1.3×	261 1.3×	65 0.5×	52	903
R. Engelhardt Germany	13	169 0.6×	250 0.9×	148 0.7×	186 0.9×	50 0.4×	33	767
Fotini Tzortzatou‐Stathopoulou Greece	20	328 1.1×	83 0.3×	565 2.8×	213 1.1×	80 0.6×	67	1.3k

Countries citing papers authored by G D Long

Since Specialization

Citations

This map shows the geographic impact of G D Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G D Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G D Long more than expected).

Fields of papers citing papers by G D Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G D Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G D Long. The network helps show where G D Long may publish in the future.

Co-authorship network of co-authors of G D Long

This figure shows the co-authorship network connecting the top 25 collaborators of G D Long. A scholar is included among the top collaborators of G D Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G D Long. G D Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sivaraj, Dharshan, Wendi Bacon, G D Long, et al.. (2017). High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma. Bone Marrow Transplantation. 53(1). 34–38. 13 indexed citations

Kanda, Junya, Leylagül Kaynar, Yoshinobu Kanda, et al.. (2013). Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. Bone Marrow Transplantation. 48(7). 926–931. 37 indexed citations

Jagasia, Madan, Rafat Abonour, G D Long, et al.. (2012). Palifermin for the reduction of acute GVHD: a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplantation. 47(10). 1350–1355. 19 indexed citations

Horwitz, Mitchell E., G D Long, Peter Holman, et al.. (2012). Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors. Bone Marrow Transplantation. 47(10). 1283–1286. 13 indexed citations

Horwitz, Mitchell E., John P. Chute, Christina Gasparetto, et al.. (2011). Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration. Bone Marrow Transplantation. 47(8). 1051–1055. 37 indexed citations

Prasad, Vinod K., Gloria Broadwater, N.L. Reinsmoen, et al.. (2011). Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors. Bone Marrow Transplantation. 47(6). 817–823. 23 indexed citations

Kanda, Junya, Mitchell E. Horwitz, G D Long, et al.. (2011). Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 47(5). 700–705. 18 indexed citations

Horwitz, Mitchell E., G D Long, Cristina Gasparetto, et al.. (2010). Plerixafor Given “Just In Time” For Peripheral Blood Stem Cell Mobilization Of Patients With Suboptimal Response To G-CSF. Biology of Blood and Marrow Transplantation. 16(2). S208–S208. 1 indexed citations

Horwitz, Mitchell E., G D Long, Cristina Gasparetto, et al.. (2007). Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection. Bone Marrow Transplantation. 41(1). 39–43. 27 indexed citations

10.

Spasojević, Ivan, Ashley Morris, G D Long, et al.. (2007). 244: Fludarabine-based non-myeloablative stem cell transplantation in a patient with sickle cell disease and renal failure. Biology of Blood and Marrow Transplantation. 13(2). 90–90. 1 indexed citations

11.

Bhagat, R, et al.. (2001). Amiodarone and cyclophosphamide: potential for enhanced lung toxicity. Bone Marrow Transplantation. 27(10). 1109–1111. 12 indexed citations

12.

Alvarnas, Joseph, Robert S. Negrin, Sandra J. Horning, et al.. (2000). High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation. 6(3). 352–358. 42 indexed citations

13.

Long, G D, Keith Stockerl‐Goldstein, Linda J. Johnston, et al.. (1999). A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.. PubMed. 5(11). 3411–8. 4 indexed citations

14.

Rizzieri, David A., James J. Vredenburgh, Roy B. Jones, et al.. (1999). Prognostic and Predictive Factors for Patients With Metastatic Breast Cancer Undergoing Aggressive Induction Therapy Followed by High-Dose Chemotherapy With Autologous Stem-Cell Support. Journal of Clinical Oncology. 17(10). 3064–3074. 49 indexed citations

15.

Kusnierz-Glaz, C., J R Schriber, N J Chao, et al.. (1997). Influence of age on the outcome of 500 autologous bone marrow transplant procedures for hematologic malignancies.. Journal of Clinical Oncology. 15(1). 18–25. 58 indexed citations

16.

O’Donnell, Margaret, G D Long, Pablo Parker, et al.. (1995). Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia.. Journal of Clinical Oncology. 13(12). 2973–2979. 51 indexed citations

17.

Horning, Sandra J., et al.. (1994). Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 12(12). 2552–2558. 68 indexed citations

18.

Schriber, J R, RS Negrin, Nelson J. Chao, et al.. (1993). The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow.. PubMed. 7(10). 1491–5. 13 indexed citations

19.

DeChatelet, Lawrence R., C. J. Lees, Christopher Walsh, G D Long, & Pamela S. Shirley. (1982). Comparison of the calcium ionophore and phorbol myristate acetate on the initiation of the respiratory burst in human neutrophils. Infection and Immunity. 38(3). 969–974. 18 indexed citations

20.

DeChatelet, Lawrence R., G D Long, Pamela S. Shirley, et al.. (1982). Mechanism of the luminol-dependent chemiluminescence of human neutrophils.. The Journal of Immunology. 129(4). 1589–1593. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact